100
Participants
Start Date
January 14, 2022
Primary Completion Date
December 9, 2024
Study Completion Date
December 9, 2024
ALXN2050
Oral tablets
Placebo
Oral tablets
Research Site, New Taipei City
Research Site, Kaohsiung City
Research Site, Westmead
Research Site, Liverpool
Research Site, Clayton
Research Site, Córdoba
Research Site, Nedlands
Research Site, Barcelona
Research Site, New York
Research Site, Berlin
Research Site, Torino
Research Site, Goyang-si
Research Site, Bangkok
Research Site, México
Research Site, Córdoba
Research Site, Girona
Research Site, Niš
Research Site, Milan
Research Site, Novi Sad
Research Site, New Taipei City
Research Site, Brescia
Research Site, Torreón
Research Site, Marburg
Research Site, Gainesville
Research Site, Istanbul
Research Site, Huntsville
Research Site, Taichung
Research Site, Seville
Research Site, Guadalajara
Research Site, Essen
Research Site, Valencia
Research Site, Busan
Research Site, Des Moines
Research Site, Ramat Gan
Research Site, Mainz A. Rhein
Research Site, Kansas City
Research Site, Mannheim
Research Site, Bari
Research Site, McKinney
Research Site, Houston
Research Site, Ashkelon
Research Site, Napoli
Research Site, Nampa
Research Site, Albuquerque
Research Site, Northridge
Research Site, Loma Linda
Research Site, Shanghai
Research Site, Guangzhou
Research Site, Haifa
Research Site, Petah Tikva
Research Site, Ciudad de Buenos Aires
Research Site, La Plata
Research Site, Rosario
Research Site, Belo Horizonte
Research Site, Curitiba
Research Site, Juiz de Fora
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Salvador
Research Site, München
Research Site, Seoul
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Research Site, Palma de Mallorca
Research Site, Bristol
Research Site, Cambridge
Research Site, Doncaster
Research Site, Leicester
Research Site, London
Research Site, London
Research Site, Manchester
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY